首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Recombinant Human FLRG Protein, C-His Tag

Recombinant Human FLRG Protein, C-His Tag

产品编号

KRP062

别名

Follistatin相关蛋白3, Follistatin-related protein 3 , Follistatin-like protein 3, Follistatin-related gene protein, FLRG, UNQ674/PRO1308,

规格
  • 20ug
  • 50ug
  • 100ug
  • 200ug
  • 1mg
产品介绍
Catalog NumberKRP062
AliasFollistatin相关蛋白3, Follistatin-related protein 3 , Follistatin-like protein 3, Follistatin-related gene protein, FLRG, UNQ674/PRO1308,
Size20ug, 50ug, 100ug, 200ug, 1mg
Product DescriptionHuman FSTL3(27-263 aa)
Molecular NameFSTL3
Product IntroductionFollistatin相关蛋白3通过抑制血管生成,参与肿瘤进展的调控因子。。
Molecular Weight38 kDa
Expression SystemHEK293F Cells
SpeciesHuman
Concentration联系销售经理获得最新批次的浓度
Purity≥90%
SDS-PAGE
PurificationAffinity Purification
Uniprot IDO95633
Storage ConditionStore the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles.
FormulationSupplied in PBS
Shipping ConditionThis product is shipped on ice packs or dry ice.
BackgroundIsoform 1 or the secreted form is a binding and antagonizing protein for members of the TGF-beta family, such as activin, BMP2 and MSTN. Inhibits activin A-, activin B-, BMP2- and MSDT-induced cellular signaling; more effective on activin A than on activin B. Involved in bone formation; inhibits osteoclast differentiation. Involved in hematopoiesis; involved in differentiation of hemopoietic progenitor cells, increases hematopoietic cell adhesion to fibronectin and seems to contribute to the adhesion of hematopoietic precursor cells to the bone marrow stroma. Isoform 2 or the nuclear form is probably involved in transcriptional regulation via interaction with MLLT10. {ECO:0000269|PubMed:11948405, ECO:0000269|PubMed:15451575, ECO:0000269|PubMed:15574124, ECO:0000269|PubMed:16336961, ECO:0000269|PubMed:17868029, ECO:0000269|PubMed:17878677}.
Endotoxin< 0.1 EU per ug
Biological ActivityMeasured by its ability to neutralize Activin mediated erythroid differentiation of K562 human chronic myelogenous leukemia cells. The ED50 forthis effect is 3-15 ng/mL in the presence of 7.5 ng/mL recombinant human Activin A.
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价